Molecular Diagnostics

Devyser is a pioneer in advanced DNA testing, committed to transforming genetic diagnostics through simplicity and speed. Founded in Stockholm in 2004 by three researchers determined to improve patient care, Devyser developed a groundbreaking single-tube assay that drastically shortened testing times and streamlined lab workflows.

Today, Devyser’s user-friendly diagnostic kits are trusted by laboratories in over 45 countries, enabling faster, more accurate results and accelerating patient access to the right treatment. With a growing team and a relentless focus on relevance, empathy, and simplicity, Devyser continues to lead the way in making personalized medicine more accessible and effective worldwide.

SML Genetree is a global leader in molecular diagnostics, driven by the mission of creating a healthier world through the concept of ‘Smart Medical Life’. Originating in South Korea, the company has rapidly earned international recognition for its innovative diagnostic solutions targeting infectious diseases.

With over 53 products developed and a presence in more than 33 countries, SML Genetree combines cutting-edge research with large-scale production capabilities, manufacturing over 10 million tests annually under rigorous GMP standards. At its core, the company is guided by values of communication, trust, innovation, and happiness, ensuring that every solution delivered supports accurate diagnosis and a better quality of life for patients worldwide.

SD Biosensor is a global in-vitro diagnostics company dedicated to improving health outcomes through fast and accurate disease detection. With a focus on infectious disease diagnostics, the company offers a wide range of testing platforms, including molecular diagnostics, fluorescent immunoassays, and immunochromatography, designed to support both screening and confirmatory testing.

Headquartered in South Korea with a global presence across Asia, the Americas, and Europe, SD Biosensor plays a key role in strengthening diagnostic capacity worldwide. Guided by a commitment to technological progress and public health, the company aims to make reliable diagnostics more accessible wherever they are needed most.

Ustar Biotechnologies specializes in point-of-care molecular diagnostics, offering compact, integrated testing solutions for infectious diseases. Since its founding in 2005, the company has developed proprietary technology supported by over 90 patent applications, including 45 granted patents, and has played a key role in national public health initiatives in China.

Ustar’s diagnostic systems simplify the entire testing process, combining nucleic acid extraction, amplification, and detection in a single, enclosed cartridge. These easy-to-use kits deliver reliable results quickly and safely, with a sensitivity of ≤200 copies/mL. Used by nearly 3,000 medical institutions and exported to more than 70 countries, Ustar is helping bring molecular diagnostics to more people, in more places, under the vision: Molecular Testing Anywhere.

BioPerfectus is a molecular diagnostics company focused on infectious diseases and public health, with a growing presence in more than 100 countries. Founded in 2010, the company offers a broad portfolio of over 700 products that support hospitals, laboratories, and disease control centers around the world.

By integrating research and development, core material production, and diagnostic services, BioPerfectus delivers accurate and efficient testing solutions that support early detection and effective disease management. With continued investment in point of care testing and international expansion, the company is guided by a clear mission to improve global health and contribute to a healthier future through trusted diagnostics.

Genolution is a biotechnology company specializing in nucleic acid extraction technologies for molecular diagnostics, genetic testing, and life sciences research. Since its founding in 2006, Genolution has focused on improving the speed, efficiency, and affordability of extraction workflows. This effort led to the development of the Nextractor® series, a line of high-throughput and cost-effective extraction instruments and kits designed to improve efficiency and consistency in diagnostic workflows.

With a commitment to innovation and global collaboration, Genolution partners with research institutions, healthcare organizations, and industry leaders to support high-quality diagnostic and scientific work. Now publicly listed on KOSDAQ, the company continues to advance reliable solutions in molecular diagnostics while expanding its impact in life sciences.

VWR, now part of Avantor, provides essential consumables that support every stage of molecular diagnostics workflows. Known for its broad product offering and strong distribution network, VWR plays a vital role in ensuring laboratories have consistent access to the tools and materials they need for reliable testing.

As part of Avantor’s global platform, VWR benefits from vertically integrated capabilities, extensive manufacturing and distribution infrastructure, and a commitment to quality that meets the demands of regulated environments. With over 75 global facilities, including cGMP and ISO-certified sites, and more than six million products distributed worldwide, Avantor and VWR together offer dependable supply chain support for molecular diagnostics and life science research.

When the coronavirus 2019 (COVID-2019) outbreak, 3DMed responded rapidly by developing a series of RT-qPCR-based tests (the ANDiS SARS-CoV-2 Detection Kit and the ANDiS SARS-CoV-2 & Influenza A/B Detection Kit) for qualitative detection of SARS-CoV-2 RNA in upper and lower respiratory specimens collected from individuals who meet the CDC criteria for SARS-CoV-2 testing.

Based on the advantage of PNA material and accumulated knowledge, Panagene have developed various innovative platform technologies on molecular diagnostics covering multiplexing, mutated gene specific amplification, SNP discrimination and so on. To meet rapidly changing diagnostic market needs.

PANAGENE has expertise especially in cancer-related molecular diagnostics including companion diagnostics using tissue or liquid biopsy specimens. Panagene advanced technology provides not only high level of detection but also simple and convenient procedure to be used easily in the front-line hospitals and clinical laboratories by themselves.